Galena Biopharma Aktie
WKN DE: A2JAX8 / ISIN: US81642T1007
21.05.2025 12:45:16
|
Solaris Resources Enters $200 Mln Financing Arrangement
(RTTNews) - Solaris Resources has entered into a $200 million financing arrangement comprising a gold stream and net smelter return royalty with RGLD Gold AG, a subsidiary of Royal Gold, Inc. The company said the Financing Agreements provide the company with long-term liquidity required to fund all value accretive, derisking activities through to a final investment decision, in addition to paying off the senior secured debt facility with Orion Mine Finance Management LP.
Royal Gold will pay Solaris a total cash consideration of $200 million in three instalments.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Galena Biopharma Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Galena Biopharma Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Royal Gold Inc. | 137,45 | -0,90% |
|